Please Note:
This profile was automatically generated using 18 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 18 references found on the Internet. This information has not been verified. Learn more...
View all 18 references Web References
-
1. www.chinesedc.com
www.chinesedc.com/cba/CBA%207t - [Cached]Published on: 9/19/2002 Last Visited: 11/9/2006
Hai Shiene Chen, M.D., President & CEO, ACGT Corporation
AMIGAP Technology and its Application -
2. Yahoo - Asdar Group Announces Agreement With Biotechnology Company, ACGT Corporation
biz.yahoo.com/em/020114/heuhli - [Cached]Published on: 1/14/2002 Last Visited: 1/14/2002
ACGT, founded in 1995 by Dr. Hai Shiene Chen, M.D., M.S., and Dr. Qi Jia, M.D., is a privately-held biotechnology company which focuses on three distinct areas of interest: DNA Technology Services, DNA Diagnostic Systems and Gene Therapy. -
3. Dr. Chen
www.cba-usa.org/speaker/Chen.h - [Cached]Published on: 8/12/2001 Last Visited: 5/1/2004
Dr. Hai Shiene Chen, was educated at The Second Military Medical University, Shanghai, China. He received his Medical Degree in 1983, graduating in the top 2% of his class. Between 1986 and 1988, Dr. Chen trained at Harvard Medical School in the field of cancer research. In 1990, Dr. Chen obtained a M. Sc. Degree from the University of Toronto, and while there, directed a research project on HIV. From 1991 to 1996, Dr. Chen was a Managing Director for the Canadian Genetic Diseases Network's Core Facility. In 1995, Dr. Chen founded ACGT Corporation, which in four short years has become a leader in Canada's DNA businesses.
Dr. Chen has demonstrated the skills necessary to identify opportunity and initiate an action planning process to achieve results. He has successfully managed a multi-service international operation, and is widely respected in the medical technology community for his efficiency. To date, Dr. Chen is the sole inventor for ACGT's patents. Dr. Chen has demonstrated the ability to initiate and move an idea forward, and is a key value driver for ACGT.

